Neuro-oncology advances
Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis.
Neuro-oncology advances
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.
Neuro-oncology advances
Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study.
Neuro-oncology advances
ECOA-5. Integrative 3D spatial characterization of genomic and epigenomic intratumoral heterogeneity in glioblastoma.
Neuro-oncology advances
Mouse models of glioblastoma for the evaluation of novel therapeutic strategies.
Neuro-oncology advances
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
Neuro-oncology advances
TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group.
Neuro-oncology advances